Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 5, 2011, Pages 354-361

  Guo, Ning ^a   Chen, Rufu ^a   Li, Zhihua ^a   Liu, Yonggang ^a   Cheng, Di ^a   Zhou, Quanbo ^a   Zhou, Jiajia ^a   Lin, Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

DNA methylation; HCV; hilar cholangiocarcinoma; histone methyltransferase

Indexed keywords

HEPATITIS C ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; PRIMER DNA; RASSF1 PROTEIN, HUMAN; SMYD3 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; DNA METHYLATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CHOLANGIOCARCINOMA; DNA METHYLATION; DNA PRIMERS; HEPATITIS C ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

HEPATITIS C VIRUS;

EID: 79955431726     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr021     Document Type: Article

References (25)

1. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA and McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 2007, 5: 1221-1228. (Pubitemid 47496233)
2. Suriawinata A and Thung SN. Hepatitis C virus and malignancy. Hepatol Res 2007, 37: 397-401. (Pubitemid 46915782)
3. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T and Takemura S, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004, 95: 592-595. (Pubitemid 39089641)
4. Chen RF, Li ZH, Liu RY, Kong XH, Tang QB and Wang J. Malignant transformation of the cultured human normal biliary tract epithelial cells induced by hepatitis C virus core protein. Oncol Rep 2007, 17: 105-110.
5. Li ZH, Tang QB, Wang J, Zhou L, Huang WL, Liu RY and Chen RF. HCV core protein induces malignant transformation of biliary epithelial cells by activating NF-kB pathway. J Gastroenterol Hepatol 2010, 25: 1315-1320.
6. Nasimuzzaman M, Waris G, Mikolon D, Stupack DG and Siddiqui A. Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 2007, 81: 10249-10257. (Pubitemid 47463300)
7. Yang B, House MG, Guo M, Herman JG and Clark DP. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangio-carcinoma. Mod Pathol 2005, 18: 412-420. (Pubitemid 40395361)
8. Schneider R, Bannister AJ and Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 2002, 27: 396-402. (Pubitemid 34874749)
9. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M and Yagyu R, et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004, 6: 731-740. (Pubitemid 39144478)
10. Sims RJ and Reinberg D. From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat Cell Biol 2004, 6: 685-687. (Pubitemid 39144469)
11. Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y and Furukawa Y. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci 2006, 97: 113-118. (Pubitemid 43379478)
12. Chen LB, Xu JY, Yang Z and Wang GB. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J Gastroenterol 2007, 43: 5718-5724. (Pubitemid 350120224)
13. Zou JN, Wang SZ, Yang JS, Luo XG, Xie JH and Xi T. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF. Cancer Lett 2009, 280: 78-85.
14. Tsuge M, Hamamoto R, Silva FP, Ohnishi Y, Chayama K, Kamatani N and Furukawa Y, et al. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 50 flanking region of SMYD3 is a risk factor for human cancers. Nat Genet 2005, 37: 1104-1107. (Pubitemid 41486663)
15. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000, 25: 315-319. (Pubitemid 30437320)
16. Shivakumar L, Minna J, Sakamaki T, Pestell R and White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002, 22: 4309-4318. (Pubitemid 34556598)
17. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP and Avruch J. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002, 21: 1381-1390. (Pubitemid 34214503)
18. Kee SK, Lee JY, Kim MJ, Lee SM, Jung YW, Kim YJ and Park JY, et al. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer. Mol Cells 2007, 24: 364-371.
19. Chen YJ, Tang QB and Zou SQ. The research of RASSF1A gene in extrahepatic cholangiocarcinoma transcription and its clinical significance. Zhong Hua Gan Dan Wai Ke Za Zhi 2005, 11: 107-109.
20. Zuo S, Chen Y, Xu L, Tang Q and Zou S. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 2007, 27: 281-284.
21. Chen YJ, Tang QB and Zou SQ. The research of sporadic extrahepatic cholangiocarcinoma RASSF1A gene promoter methylation status. Zhong Hua Shi Yan Wai Ke Za Zhi 2004, 21: 1430-1432.
22. Tang QB, Sun HW and Zhou SQ. Inhibitory effect of methylation inhibitor 5-aza-2-deoxycytidine on bile duct cancer cell line in vivo and in vitro. Hepatobiliary Pancreat Dis Int 2004, 3: 124-128.
23. Yoo CB and Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006, 5: 37-50.
24. Donninger H, Vos MD and Clark GJ. The RASSF1A tumor suppressor. J Cell Sci 2007, 120: 3163-3172. (Pubitemid 350018407)
25. Tamaru H and Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 2001, 414: 277-283. (Pubitemid 33097798)